share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Burrell Terry-Ann
美股sec公告 ·  06/06 06:17
牛牛AI助理已提取核心訊息
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following this transaction, Burrell's direct holdings in the company increased to a total of 69,411 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following this transaction, Burrell's direct holdings in the company increased to a total of 69,411 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell，有關Recursion Pharmaceuticals, Inc. [RXRX]，於2024年6月3日完成一宗股票收購。該交易涉及免費贈予13,097股A類普通股份。此後，Burrell在該公司的直接持股增至合共69,411股。該贈予是該公司的股份報酬計劃的一部分，反映其將員工與股東的利益相互調和的持續承諾。
Terry-Ann Burrell，有關Recursion Pharmaceuticals, Inc. [RXRX]，於2024年6月3日完成一宗股票收購。該交易涉及免費贈予13,097股A類普通股份。此後，Burrell在該公司的直接持股增至合共69,411股。該贈予是該公司的股份報酬計劃的一部分，反映其將員工與股東的利益相互調和的持續承諾。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。